Avacta Appoints David Liebowitz as CMO, Yulii Bogatyrenko as Advisor
July 1, 2025
Avacta Group, a life sciences company developing innovative, targeted oncology drugs, announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii